August 2022

home / publications / evidence-based-oncology / august-2022
Advancing Cancer Care Equity: Yes, and…

Advancing Cancer Care Equity: Yes, and…

Joseph Alvarnas, MD
August 18th 2022
ArticleFROM THE EDITORS
Takeda Partnership With Xavier University Seeks Blueprint to Advance Health Equity

Takeda Partnership With Xavier University Seeks Blueprint to Advance Health Equity

Mary Caffrey
August 18th 2022
Article
NPC Weighs in on PBM Inquiry; Radiologist Receives Award; OneOncology Creates Disease Groups

NPC Weighs in on PBM Inquiry; Radiologist Receives Award; OneOncology Creates Disease Groups

AJMC Staff
August 17th 2022
ArticleFROM OUR PARTNERS

News from Strategic Alliance Partners of The American Journal of Managed Care®.

Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings

Trilaciclib Before Chemotherapy May Prevent Hematological Events—With Savings

Mary Caffrey
August 16th 2022
Article
Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care

Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care

Laura Joszt, MA
August 16th 2022
Article

The Institute for Value-Based Medicine series visits Texas Oncology in Austin.

How Advocacy Groups and Patient Data Can Help Drive Health Equity

How Advocacy Groups and Patient Data Can Help Drive Health Equity

Adam Mariano, Esq, MSPH
August 15th 2022
Article
Taking Action to Address Health Equity in Oncology

Taking Action to Address Health Equity in Oncology

Susan Shiff, PhD, MBA
August 15th 2022
Article

New Enhancing Oncology Model Builds on Knowledge From the OCM

New Enhancing Oncology Model Builds on Knowledge From the OCM

Stuart Staggs, MSIE
August 15th 2022
ArticleCOVER FEATURE
OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services

OCM Successor Puts Focus on Equity in Cancer Care—With Fewer Dollars for Services

Mary Caffrey
August 15th 2022
ArticleCOVER FEATURE
Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies

Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies

Natasha Khrystolubova, BPharm, RPh, BCOP;Ray Bailey, RPh;Roger Orr, PharmD, BCOP;Lucio Gordan, MD;Trista Auger, RPhT, CPhT
August 11th 2022
ArticlePEER REVIEWED
A Call to Action: Oncology Practices—and Patients—Need Performance Measures for Managing Oral Therapies

A Call to Action: Oncology Practices—and Patients—Need Performance Measures for Managing Oral Therapies

Natasha Khrystolubova, BPharm, RPh, BCOP;Ray Bailey, RPh;Roger Orr, PharmD, BCOP;Lucio Gordan, MD;Trista Auger, RPhT, CPhT
August 11th 2022
ArticleEDITORIAL
Zelenetz Discusses How to Evaluate Responses to Therapy in DLBCL

Zelenetz Discusses How to Evaluate Responses to Therapy in DLBCL

AJMC Staff
June 22nd 2022
Article

Andrew Zelenetz, MD, PhD, medical oncologist at Memorial Sloan Kettering Cancer Center, is the current chair of the Non-Hodgkin Lymphoma Guidelines panel of the National Comprehensive Cancer Network (NCCN).

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action

Kashyap Patel, MD;Hirangi Mukhi, BS;Anjana Patel, BSc;Niyati Nathwani, MD;Dhwani Mehta, MS;Jennifer Sherak, MBA;Natasha Clinton, MSN, APRN, AOCNP;Holly Pisarik, JD;Benjamin Brown, BS;Sara Rogers, PharmD;Mary Kruczynski;Nicolas Ferreyros, BA;Ted Okon, MBA
March 15th 2022
Article

No One Left Behind, a program to provide financial assistance and access to cancer care at Carolina Blood and Cancer Care Associates in South Carolina, will be discussed during a session of the Community Oncology Alliance 2022 Community Oncology Conference.

Patel et al, Appendix B

Patel et al, Appendix B

March 15th 2022
Article
Patel et al Appendix A

Patel et al Appendix A

March 15th 2022
Article

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo